Advertisement

Reactions Weekly

, Volume 1761, Issue 1, pp 85–85 | Cite as

Bevacizumab/capecitabine/irinotecan

Neutropenia: case report
Case report
  • 8 Downloads

Reference

  1. Yukimoto R, et al. XELIRI plus bmab therapy as a secondary treatment for recurrent colorectal cancer with long-term survival. [Japanese]. Gan to Kagaku Ryoho 46: 369-371, No. 2, Feb 2019. Available from: URL: https://www.researchgate.net/publication/332058575_XELIRI_plus_Bmab_Therapy_as_a_Secondary_Treatment_for_Recurrent_Colorectal_Cancer_with_Long-Term_Survival [Japanese; summarised from a translation] - Japan

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations